A prospective open-label non-randomized study to assess whether presence of optimized Subharmonic imaging signals inside hepatic vein can be used as a screening test for portal hypertension after infusion of the ultrasound contrast agent Sonazoid
Latest Information Update: 10 Jan 2021
At a glance
- Drugs Perflubutane (Primary)
- Indications Portal hypertension
- Focus Diagnostic use
- 10 Jan 2021 New trial record
- 04 Jan 2021 Results published in the Digestive Diseases and Sciences